Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.

Ginzler, E; Diamond, H; Guttadauria, M; Kaplan, D

dc.contributor.author	Ginzler, E
dc.contributor.author	Diamond, H
dc.contributor.author	Guttadauria, M
dc.contributor.author	Kaplan, D
dc.date.accessioned	2023-02-03T16:34:04Z
dc.date.available	2023-02-03T16:34:04Z
dc.identifier.citation	Ginzler E, Diamond H, Guttadauria M, Kaplan D. Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis. Arthritis Rheum. 1976 Jul-Aug;19(4):693-9. doi: 10.1002/1529-0131(197607/08)19:4<693::aid-art1780190406>3.0.co;2-2. PMID: 782464.	en_US
dc.identifier.issn	0004-3591
dc.identifier.pmid	782464
dc.identifier.uri	http://hdl.handle.net/20.500.12648/8219
dc.description.abstract	A 1-year double-blind crossover study comparing prednisone and azathioprine to prednisone plus low-dose azathioprine and cyclophosphamide was carried out in 14 patients with diffuse lupus nephritis. Low-dose triple therapy had no apparent therapeutic advantage over prednisone plus azathioprine. Cyclophosphamide-induced ovarian failure and hematuria were not avoided by its use in low dose.
dc.language.iso	en	en_US
dc.relation.url	https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0004-3591&date=1976&volume=19&issue=4&spage=693	en_US
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.title	Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.	en_US
dc.type	Article/Review	en_US
dc.source.journaltitle	Arthritis and rheumatism	en_US
dc.source.volume	19
dc.source.issue	4
dc.source.beginpage	693
dc.source.endpage	9
dc.source.country	United States
dc.description.version	VoR	en_US
refterms.dateFOA	2023-02-03T16:34:04Z
html.description.abstract	A 1-year double-blind crossover study comparing prednisone and azathioprine to prednisone plus low-dose azathioprine and cyclophosphamide was carried out in 14 patients with diffuse lupus nephritis. Low-dose triple therapy had no apparent therapeutic advantage over prednisone plus azathioprine. Cyclophosphamide-induced ovarian failure and hematuria were not avoided by its use in low dose.
dc.description.institution	SUNY Downstate	en_US
dc.description.department	Rheumatology	en_US
dc.description.degreelevel	N/A	en_US
dc.identifier.journal	Arthritis and rheumatism